eLife is a non-profit organisation inspired by research funders and led by scientists. Our mission is to help scientists accelerate discovery by operating a platform for research communication that ...
A structural abnormality can include an alteration to the structure of the chromosome, as the name suggests. However, a numerical abnormality means that an individual is either missing one of the ...
Your DNA may predict more about you than the way you look. According to the genetic theory of aging, your genes (as well as mutations in those genes) are responsible for how long you'll live. Here's ...
Enlisting an international team of collaborators, the researchers looked at several families with different genetic disorders affecting their immune systems. In each case, the disease-causing copy ...
The pair had helped identify a still-unnamed disease, which they had tied to a particular gene and to a particular somatic mutation—a genetic change that had not been passed down from a parent ...
the hepatic lesions seen in such metabolic disorders as galactosemia and tyrosinosis. At present, however, no biochemical disorder has been demonstrated in infants with Etrisomy. Furthermore ...
Metabolic disorders like galactosemia or trauma during or after ... causes of infant cataracts are preventable like in case of genetic predispositions, many risks can be significantly reduced ...
Genetic testing for all citizens intending to get married across the UAE will be a part of the mandatory premarital screening programme from January 2025. While premarital medical examination was ...
Now, on this morning in September 2021, Linde would find out if she had inherited the same vile genetic mutation. She had a bad feeling. She and her mother had been so alike. Allison had been a ...
Conventional investigations of the genetic contributors to Alzheimer's disease (AD) risk and progression have ignored the role of the X-chromosome, primarily due to technical analysis limitations.
In a statement, Applied Therapeutics said that the FDA had cited “deficiencies in the clinical application” of the genetic drug as the main reason it declined to approve it for commercial sale ...